We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.
BLPH

Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

19 hedge funds and large institutions have $1.18M invested in Bellerophon Therapeutics, Inc. in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 19 → 19 (0)

16% less capital invested

Capital invested by funds: $1.4M → $1.18M (-$217K)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$429
2
JP Morgan Chase
JP Morgan Chase
New York
+$10
3
Wells Fargo
Wells Fargo
California
+$8

Top Sellers

Rank Fund Capital Flow
1
TI
Telemetry Investments
New York
-$28.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$20.4K
3
Renaissance Technologies
Renaissance Technologies
New York
-$17.3K
4
TRCT
Tower Research Capital (TRC)
New York
-$4.01K
5
Morgan Stanley
Morgan Stanley
New York
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$376K -$20.4K -15,596 -4%
Wells Fargo
2
Wells Fargo
California
$218K +$8 +6 +0%
Renaissance Technologies
3
Renaissance Technologies
New York
$214K -$17.3K -13,208 -6%
BlackRock
4
BlackRock
New York
$110K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$70K – – –
TI
6
Telemetry Investments
New York
$52K -$28.1K -21,500 -31%
Northern Trust
7
Northern Trust
Illinois
$31K – – –
SC
8
Sepio Capital
Utah
$26K – – –
State Street
9
State Street
Massachusetts
$23K – – –
Tudor Investment Corp
10
Tudor Investment Corp
Connecticut
$22K – – –
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$16K +$429 +328 +2%
DWM
12
Destination Wealth Management
California
$11K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$8K -$4.01K -3,064 -29%
Morgan Stanley
14
Morgan Stanley
New York
$2K -$4 -3 -0.2%
Northwestern Mutual Wealth Management
15
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$1K – – –
US Bancorp
17
US Bancorp
Minnesota
$1K – – –
JP Morgan Chase
18
JP Morgan Chase
New York
– +$10 +8 +8%

BLPH Hedge Fund Activity: Q3 2022 in Review

19 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q3 2022, worth a combined $1.18M — down 16% from $1.4M a quarter earlier.

Fund positioning in BLPH was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $429. The largest seller was Telemetry Investments, cutting an estimated $28.1K.

  • 19 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $1.18M of Bellerophon Therapeutics, Inc. stock for Q3 2022, down 16% quarter-over-quarter.
  • 0 funds opened new Bellerophon Therapeutics, Inc. positions in Q3 2022 and 0 closed out.
  • The largest Bellerophon Therapeutics, Inc. buyer in Q3 2022 was Susquehanna International Group, an estimated $429 added.
  • The largest Bellerophon Therapeutics, Inc. seller in Q3 2022 was Telemetry Investments, an estimated $28.1K sold.

Based on aggregated 13F filings for Q3 2022.